The Advocate: Supporting the Patient Voice Releases 2026 U.S. Focused Patient Advocacy Report

The Advocate: Supporting the Patient Voice is excited to announce the results of its 2026 U.S. Focused Patient Advocacy report. The report provides an in-depth look at feedback from Patient Advocacy Organizations & Professional Societies/Associations and their relationship with the pharmaceutical community. This information will help stakeholders understand new & innovative ways they can best work with Patient Advocacy Organizations & Professional Societies/Associations to improve healthcare for all patients. The Advocate would like to thank their many sponsors in the pharmaceutical community for making this report possible & for the respondents who gave their time & feedback!

• For the 8th consecutive year, Johnson & Johnson Innovative Medicine ranked #1 for patient advocacy. Johnson & Johnson Innovative Medicine demonstrated the strongest year over improvement for Corporate Reputation.  Johnson & Johnson Innovative Medicine is noted for “consistently including the patient experience," as well as “commitment to innovation," their “access to leadership” and “emphasis on collaboration." 

• AbbVie, Sanofi and Novartis showed improvement and moved up in 4 out of 5 benchmarking categories. 
  • AbbVie demonstrated the strongest year over improvement for Advancing Patient Treatment.  AbbVie is noted for their “commitment to educating their field staff," their “focus on improving patient education and encouraging honest discussions between patients and their doctors” and “continued investment in innovative therapies and research that expand treatment options."
  • Sanofi demonstrated the strongest year over improvement for Policy Support. Patient advocates noted Sanofi “reaches out early and often,"  along with their “collaboration with patient advocacy organizations” and how they “work to understand patient experience."
  • Novartis is noted for “building bridges across patient advocacy organizations and developing medications that will improve the quality of life for patients," their “advisory boards” and “innovation."

• Merck showed improvement and moved up in 3 out of 5 benchmarking categories.
  • Merck stands out for their “proactive engagement with diverse patient advocacy groups” and “scientific innovation with deep partnerships." 

• For the 6th year in a row, Pfizer has remained consistent, placing 2nd in Patient/Professional Group Relations.  Pfizer is noted for “their engagement and collaboration” and “listening to the patient’s voice."

The Advocate: Supporting the Patient Voice's goal is to understand the relationship between advocates & the pharmaceutical industry. It's their mission to ensure that patients remain at the center of all healthcare decisions - may it be in their doctor's office, within the walls of the Payer of PBM or up on Capitol Hill. We understand that the pharmaceutical community aligns with their mission in their goals to ensure patients get access to the products they & their physicians have decided. It seeks to serve as a beacon for the pharmaceutical community to always find their way back to the patient by elevating the voice of their loudest supporters – the advocacy organizations. The Advocate does this through a syndicated market research offering for the pharmaceutical community to gain insights into the needs of the patients they serve & the patient advocate organizations they fight side by side with on numerous issues. 

The research and expertise of The Advocate allows them to guide today's pharmaceutical advocacy teams, aid in the development & implementation of patient centricity programs within pharmaceutical companies & consult on the use of the patient voice throughout the products lifecycle. Reach out to Ryan & his team directly with any questions about the current report, or any previous or future reports at [email protected] or www.TheBrooksGroupOnline.com.